p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomarivus status

Oncogene

Volumn 15, Issue 14, 1997, Pages 1737-1740

  McGregor, Jane M ^a   Berkhout, Ron J M ^b   Rozycka, Magdalena ^d   Ter Schegget, Jan ^b   Bouwes Bavinck, Jan N ^c   Brooks, Louise ^e   Crook, Tim ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Human papillomavirus; Non melanoma skin; p53 gene; Transplantation

Indexed keywords

PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CANCER; SUNLIGHT; TRANSPLANTATION; ULTRAVIOLET IRRADIATION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030690038     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201339     Document Type: Article

References (28)

1. Berkhout JM, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ and ter Schegget J. (1995). J. Clin. Microbiol., 33, 690-695.
2. Birkeland SA, Storm HH and Lamm LU, (1995). Int. J. Cancer, 60, 183-189.
3. Blum HF. (1948). J. Natl. Inst. Cancer, 9, 247-258.
4. Bouwes Bavinck JN, de Boer A and Vermeer BJ. (1993). Br. J. Dermatol., 129, 242-249.
5. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ and Ponten J. (1991). Proc. Natl. Acad. Sci. USA, 88, 10124-10128.
6. Cheng KCDS, Cahill H and Kasai S. (1992). J. Biol. Chem., 267, 166-172.
7. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH. (1992). Lancet, 339, 1070-1073.
8. Doll R and Kinlen L. (1970). Br. Med. J., 4, 420-422.
9. Greenblatt MS, Grollman AP and Harris CC. (1996). Cancer Res., 56, 2130-2136.
10. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, Vermeer BJ and Vandenbroucke JP. (1990). Transplantation, 49, 506-509.
11. IARC. (1995). IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, vol 64, Lyon.
12. Iftner T, Bierfelder S, Csapo Z and Pfister H. (1988). J. Virol, 62, 3655-3661.
13. Jego N, Thomas G and Hamelin R. (1993). Oncogene, 8, 209-213.
14. Kelly GE, Meikle W and Sheil AGR. (1987). Br. J. Dermatol., 117, 429-440.
15. Kiyono T, Nagashima K and Ishibashi M. (1989). Virology, 173, 551-565.
16. Lennard L, Thomas S, Harrington CJ and Maddocks JL. (1985). Br. J. Dermatol., 113, 723-729.
17. Lewandowsky F and Lutz W. (1922). Arch. Dermatol. and Syphil., 141, 193-203.
18. London NJ, Farmery SM and Will EJ. (1995). Lancet, 346, 403-406.
19. McGregor JM and Proby CM. (1995). Lancet, 346, 964-965.
20. McGregor JM and Proby CM. (1996). Cancer Surveys, 26, 219-236.
21. Morris JD, Eddleston AL and Crook T. (1995). Lancet, 346, 754-758.
22. Nataraj AJ, Trent JC and Honnavara N. (1995). Photochem. Photobiol., 62, 218-230.
23. Piette J. (1991). J. Photochem. Photobiol., 11, 241-260.
24. Prives C. (1994). Cell, 78, 543-546.
25. Steger G and Pfister H. (1992). Arch. Virol., 125, 355-360.
26. Swann PF, Waters TR, Moulton DC, Xu Y-Z, Zheng Q, Edwards M and Mace R. (1996). Science, 273, 1109-1111.
27. Woodworth CD, Doniger J and DiPaolo JA. (1989). J. Virol., 63, 159-164.
28. Ziegler A, Leffel DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale: AE and Brash DE. (1993). Proc. Natl. Acad. Sci. USA, 90, 4216-4220.